Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

A Dissonance-Based Obesity Intervention

2 juni 2022 uppdaterad av: Sylvia Herbozo, University of Illinois at Chicago

Enhanced Project Health: A Dissonance-Based Intervention for Obesity in Young Adults

This project will examine the feasibility and acceptability of Enhanced Project Health, a dissonance-based obesity intervention, and whether this intervention results in significantly greater reductions in weight and improvements in lifestyle behaviors than an assessment only condition. Participants will be young adults enrolled in college.

Studieöversikt

Status

Avslutad

Betingelser

Intervention / Behandling

Detaljerad beskrivning

Approximately 34% of college students are overweight/obese. However, few behavioral weight loss (BWL) interventions have been developed for young adults in college. Research suggests that standard BWL interventions are not addressing the needs of young adults as they have shown poorer retention rates and weight loss compared to older adults in BWL trials. Standard BWL interventions are also time-intensive and are not conducive to inexpensive dissemination.

The primary aim of this project is to examine the feasibility and acceptability of Enhanced Project Health, a dissonance-based obesity intervention for young adults enrolled in college. Enhanced Project Health is based on Project Health, a dissonance-based obesity prevention program, which has been shown to significantly decrease weight gain and future overweight/obesity onset compared to a matched intervention and minimal intervention control condition in young adults. The current intervention was expanded to consist of eight weekly group sessions and to address sleep, in addition to diet and physical activity. The secondary aim is to test the hypothesis that Enhanced Project Health will result in significantly greater reductions in weight and improvements in lifestyle behaviors compared to an assessment only condition.

Studietyp

Interventionell

Inskrivning (Faktisk)

7

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Illinois
      • Chicago, Illinois, Förenta staterna, 606012
        • Neuropsychiatric Institute, University of Illinoist at Chicago

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 25 år (Vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  1. Young adults of ages 18 to 25.
  2. Enrolled as a college student.
  3. Body mass index of 25 or more (overweight/obese) based on measured height and weight.

Exclusion Criteria:

  1. Diagnosis of bulimia nervosa according to DSM-5 criteria.
  2. Diagnosis of obstructive sleep apnea.
  3. Participation in interventions for weight loss or disordered eating behaviors.
  4. Current use of prescription drugs for weight loss or disordered eating behaviors.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Dissonance-based obesity intervention
Participants in this arm will receive Enhanced Project Health.
A dissonance-based obesity intervention consisting of eight weekly groups sessions (1.5 hours).
Inget ingripande: Assessment Only
Participants in this arm will only complete the baseline assessment and 2 month assessment. They will not receive Enhanced Project Health.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Percentage of eligible young adults that agree to participate in the study
Tidsram: Up to 1 month
This will be defined as a percentage of young adults that agree to participate in study out of the young adults screened for the study.
Up to 1 month
Time for recruitment
Tidsram: Up to 1 month
This will be defined as time (weeks and days) from initial contact with research staff to randomization into the study.
Up to 1 month
Attendance rate of participants
Tidsram: Assessed at 2 months
This will be defined as the percentage of participants attending 75% of the group sessions.
Assessed at 2 months
Retention rate of participants
Tidsram: Assessed at 2 months
This will be defined as the percentage of participants remaining in the study at the post-intervention assessment.
Assessed at 2 months
Program Evaluation Questionnaire - Each Group Session
Tidsram: Assessed from week 1 to week 8

This questionnaire was developed for this study. It will assess the acceptability of the intervention and will be administered at the end of each group session. Participants will be asked to rate the usefulness of the session on one item with a scale ranging from 1 to 5. Total scores range from 1 to 5. Higher scores indicate more usefulness.

Participants will also be asked to respond to open-ended questions about each group session. These questions will assess the most favorable aspects, least favorable aspects, and areas of improvements. Responses will be coded using a variation of the long table approach emphasizing frequency, specificity, emotion, and extensiveness. Codes will be examined to identify themes.

Assessed from week 1 to week 8
Program Evaluation Questionnaire - Overall Program
Tidsram: Assessed at week 8
This questionnaire was developed for this study. It will assess the program with regard to effectiveness and satisfaction as well as characteristics of the group leaders (clarity, knowledge, experience, respect) using a scale ranging from 1 to 5. Total scores range from 8 to 40. Higher scores indicate more favorable responses. This questionnaire will be administered at the end of the last group session.
Assessed at week 8

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Body Mass Index (kg/m^2)
Tidsram: Baseline to 2 months
Body Mass Index will be calculated using measured weight and height (kg/m^2)
Baseline to 2 months
International Physical Activity Questionnaire-Short Form (IPAQ-S)
Tidsram: Baseline to 2 months
The International Physical Activity Questionnaire-Short Form will assess walking, moderate-intensity activity, and vigorous-intensity activity. The scores for each type of physical activity are converted to MET-minutes/week as defined by the following: Walking MET-minutes/week = 3.3 * walking minutes * walking days; Moderate MET-minutes/week = 4.0 * moderate-intensity activity minutes * moderate days; Vigorous MET-minutes/week = 8.0 * vigorous-intensity activity minutes * vigorous-intensity days; Total physical activity MET-minutes/week = sum of Walking + Moderate + Vigorous MET-minutes/week scores. The total score will be computed by summing the duration (in minutes) and frequency (days) of each activity. Higher duration and frequency indicate more engagement in physical activity. The pattern of physical activity can also be classified as low, moderate, or high based on the total score.
Baseline to 2 months
Actigraph GT3XP-BTLE
Tidsram: Baseline to 2 months
An accelerometer will record physical activity for a 1 week period
Baseline to 2 months
Pittsburgh Sleep Quality Index (PSQI)
Tidsram: Baseline to 2 months
The Pittsburgh Sleep Quality Index will assess the quality and patterns of sleep using a scale ranging from 0 to 3. Total scores range from 8 to 57. Higher scores indicate greater sleep disturbances.
Baseline to 2 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Sylvia Herbozo, Ph.D., University of Illinois at Chicago

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

1 september 2021

Primärt slutförande (Faktisk)

18 februari 2022

Avslutad studie (Faktisk)

18 februari 2022

Studieregistreringsdatum

Först inskickad

22 augusti 2019

Först inskickad som uppfyllde QC-kriterierna

22 augusti 2019

Första postat (Faktisk)

28 augusti 2019

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

6 juni 2022

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

2 juni 2022

Senast verifierad

1 juni 2022

Mer information

Termer relaterade till denna studie

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • 2019-0892

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

Nej

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera